REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 133 filers reported holding REATA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.20 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $415,000 | -29.5% | 4,120 | -1.0% | 0.00% | -33.3% |
| Q2 2021 | $589,000 | +28.9% | 4,163 | -9.2% | 0.00% | +50.0% |
| Q1 2021 | $457,000 | -36.6% | 4,587 | -21.4% | 0.00% | -33.3% |
| Q4 2020 | $721,000 | +28.3% | 5,834 | +1.0% | 0.00% | 0.0% |
| Q3 2020 | $562,000 | -41.5% | 5,777 | -6.1% | 0.00% | -40.0% |
| Q2 2020 | $960,000 | +104.7% | 6,152 | +89.3% | 0.01% | +66.7% |
| Q1 2020 | $469,000 | -34.5% | 3,250 | -7.1% | 0.00% | 0.0% |
| Q4 2019 | $716,000 | +154.8% | 3,500 | 0.0% | 0.00% | +200.0% |
| Q3 2019 | $281,000 | -15.1% | 3,500 | -0.3% | 0.00% | -50.0% |
| Q2 2019 | $331,000 | +18.6% | 3,509 | +7.7% | 0.00% | +100.0% |
| Q1 2019 | $279,000 | +36.8% | 3,259 | +30.4% | 0.00% | 0.0% |
| Q3 2018 | $204,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 3,063,567 | $298,453,000 | 49.63% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 150,000 | $14,613,000 | 19.62% |
| Corriente Advisors, LLC | 300,000 | $29,226,000 | 14.82% |
| Prosight Management, LP | 114,554 | $11,160,000 | 5.31% |
| MADDEN SECURITIES Corp | 43,927 | $4,279,000 | 3.18% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $2,958,000 | 2.24% |
| Biondo Investment Advisors, LLC | 99,652 | $9,708,000 | 2.10% |
| Cormorant Asset Management, LP | 450,000 | $43,839,000 | 1.69% |
| Duquesne Family Office | 543,901 | $52,987,000 | 1.54% |
| AWH Capital, L.P. | 9,500 | $925,000 | 1.30% |